Covering drugs that help patients lose weight could significantly increase CMS spending even if only a small proportion of eligible patients opt for the treatment, researchers found as a group of medications originally designed for diabetes patients gain more attention for their weight loss use. In a recent article in the New England Journal of Medicine , public health researchers Khrysta Baig and Stacie Dusetzina of Vanderbilt University and David Kim and Ashley Leech of the University of Chicago...